The Outcome of Targeted Therapies in Patients with Poor Prognosis Metastatic Renal Cell Carcinoma

Abstract

Get full access to this article

View all access options for this article.

References

Sonpavde

, Choueiri

, Escudier

, et al. Sequencing of agents for metastatic renal cell carcinoma: Can we customize therapy?. Eur Urol, 2012; 61:307.

Motzer

, Bacik

, Schwartz

, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol, 2004; 22:454.

Motzer

, Hutson

, Tomczak

, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med, 2007; 356:115.

Dillman

, Barth

, VanderMolen

, et al. Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic renal cell cancer?. Cancer Biother Radiopharm, 2011; 26:273.